What's Going On With Jaguar Health Stock?
Portfolio Pulse from Erica Kollmann
Jaguar Health, Inc. (NASDAQ:JAGX) shares are trading lower after a 1-for-60 reverse stock split and worse-than-expected first-quarter results. The stock has dropped over 65% in the past five days and is down 85.09% year to date. The company focuses on developing plant-based, non-opioid prescription medicines for GI distress.
May 23, 2024 | 4:23 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jaguar Health shares are down significantly due to a 1-for-60 reverse stock split and worse-than-expected Q1 results. The stock has dropped over 65% in the past five days and 85.09% year to date.
The reverse stock split and poor Q1 results have led to a significant decline in Jaguar Health's stock price. The reverse split was aimed at maintaining Nasdaq listing compliance, but the poor earnings report exacerbated the decline.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100